Eversense 365’s Rollout Extends the Chronic-Care Pull-Through Model

Ascensia’s rollout of Eversense 365 highlights how chronic-care devices are evolving into recurring monitoring platforms with stronger pull-through economics.

Updated

What is this trend?

Eversense 365’s rollout shows chronic-care devices are shifting from one-time hardware sales to longer-duration monitoring relationships that pull through software, reimbursement, and channel revenue.

  • CGM is moving from sensor placement to year-long monitoring service models.
  • Reimbursement and channel access now matter as much as device performance.
  • Software integration is becoming the main lock-in for chronic-care platforms.
  • Longer-duration devices create recurring revenue beyond the initial procedure.
  • The winners will own the monitoring layer, not just the implant or sensor.

What’s the latest?

Ascensia began the first rollout of Senseonics’ FDA-cleared Eversense 365 on October 10, extending CGM from a short-cycle sensor sale into a one-year monitoring relationship.

How it developed

  1. Orchestration, compliance, and utilization are reshaping medtech value, while interoperable stacks gain ground
    • Procedure-Led Demand Is Repricing Device Markets
  2. Subscription Care Stacks, Drone-Enabled Last-Mile Monitoring, and Interoperability as the New AID Moat
    • Aging and Chronic Care Demand

Go deeper

Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.

If you invest in this industry

Stay ahead in Medical Devices & Tools

Get the weekly brief in your inbox — the developments, what they mean by vantage, and what to do next.